Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

By sjmartinez • December 4, 2023

Flack JM, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Adler SG, Fried L, Jamerson K, Toto R, Brinker M, Farjat AE, Kolkhof P, Lawatscheck R, Joseph A, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials. Kidney Med. 2023 Sep 28;5(12):100730. doi: 10.1016/j.xkme.2023.100730. PMID: 38046911; PMCID: PMC10692708.

Tags: Cardiorenal, Chronic kidney disease, Clinical Trial, Finerenone, Harbor UCLA, Nephrology, Publications, Race, Type 2 diabetes

Association of ramus intermedius with greater overall coronary plaque and stenosis burden

Ansari S, Pourafkari L, Kinninger A, Budoff MJ. Association of ramus intermedius with greater overall coronary plaque and stenosis burden. Int J Cardiovasc Imaging. 2026[...]

Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression

Ansari S, Budoff MJ. Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression. Eur Heart J Imaging Methods Pract.[...]

Structural Heart Interventions in Women with Congenital Heart Disease

Coppola JA, Barforoshi S, Chung J, Jone PN, Kulkarni A, Co-Vu J. Structural Heart Interventions in Women with Congenital Heart Disease. Curr Cardiol Rep. 2026[...]